I would have sent this in a private reply. Maybe I need to upgrade my subscription.
Here is an excellent interview by a CEO of a biotech company that discusses the process of taking a new biological agent from the beginning stages to Phase III along with all of the twists and turns that had to be made to get there while all along suffering the many highly critical Doubting Thomas's....